# Exercise Versus DDAVP in Patients With Mild Hemophilia A

> **NCT03379974** · PHASE4 · COMPLETED · sponsor: **Nationwide Children's Hospital** · enrollment: 32 (actual)

## Conditions studied

- Hemophilia A

## Interventions

- **DRUG:** DDAVP Inhalant Product
- **BEHAVIORAL:** Exercise Intervention

## Key facts

- **NCT ID:** NCT03379974
- **Lead sponsor:** Nationwide Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-31
- **Primary completion:** 2019-08-30
- **Final completion:** 2019-12-05
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2020-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03379974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03379974, "Exercise Versus DDAVP in Patients With Mild Hemophilia A". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03379974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*